Drug Side Effects

Interleukin-17A Antagonist [EPC]

Interleukin-17A Antagonist [EPC] was reported 158747 times

Drugs of the Interleukin-17A Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 REBOUND PSORIASIS 357 0.6879
1 LUPUS VULGARIS 111 0.5468
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 124 0.5345
3 DEEP VEIN THROMBOSIS POSTOPERATIVE 230 0.4415
4 RED BLOOD CELL SEDIMENTATION RATE 107 0.4131
5 SWOLLEN JOINT COUNT INCREASED 439 0.3858
6 C-REACTIVE PROTEIN 107 0.3615
7 RHEUMATIC FEVER 537 0.3503
8 MACULE 708 0.3041
9 NAIL PSORIASIS 148 0.2966
10 ENTHESOPATHY 359 0.2816
11 SERONEGATIVE ARTHRITIS 180 0.2812
12 DACTYLITIS 207 0.2742
13 SKIN PLAQUE 1879 0.2658
14 FACET JOINT SYNDROME 244 0.2635
15 PSORIATIC ARTHROPATHY 6841 0.2403
16 AXIAL SPONDYLOARTHRITIS 72 0.2286
17 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 180 0.2222
18 DISLOCATION OF VERTEBRA 205 0.2181
19 RETINITIS 144 0.2093
20 PSORIASIS 21944 0.1989
21 NAIL PITTING 65 0.1988
22 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 764 0.1911
23 DUODENAL ULCER PERFORATION 687 0.1867
24 ANKYLOSING SPONDYLITIS 1686 0.1832
25 RHEUMATOID FACTOR POSITIVE 649 0.1818
26 PALMOPLANTAR PUSTULOSIS 61 0.1763
27 SACRAL PAIN 55 0.1692
28 NEUROLOGIC NEGLECT SYNDROME 61 0.1667
29 PEMPHIGUS 1300 0.1595
30 JOINT ANKYLOSIS 77 0.1571
31 GUTTATE PSORIASIS 104 0.1527
32 LENTIGO 63 0.1486
33 HYPERMOBILITY SYNDROME 58 0.1422
34 SPONDYLOARTHROPATHY 67 0.1416
35 C-REACTIVE PROTEIN ABNORMAL 540 0.1343
36 LOWER RESPIRATORY TRACT INFECTION VIRAL 50 0.1319
37 HAND DEFORMITY 1151 0.1266
38 INFLAMMATORY PAIN 65 0.1265
39 PERIPHERAL VENOUS DISEASE 237 0.1242
40 HELICOBACTER INFECTION 747 0.1204
41 PUSTULE 155 0.1149
42 X-RAY ABNORMAL 98 0.1112
43 BONE EROSION 280 0.1110
44 SYNOVITIS 1464 0.1087
45 SYMPTOM RECURRENCE 348 0.1074
46 SEBORRHOEIC KERATOSIS 135 0.1067
47 DRUG TOLERANCE DECREASED 198 0.1038
48 DECREASED IMMUNE RESPONSIVENESS 740 0.1035
49 SACROILIITIS 158 0.1032
50 TENOSYNOVITIS 243 0.1009
51 MYCOTIC ALLERGY 57 0.0997
52 FOLLICULITIS 579 0.0985
53 GRANULOMA SKIN 69 0.0960
54 ERYTHRODERMIC PSORIASIS 64 0.0958
55 CAROTID ARTERY THROMBOSIS 59 0.0946
56 PUSTULAR PSORIASIS 261 0.0942
57 DEVICE DISPENSING ERROR 61 0.0916
58 CUTANEOUS T-CELL LYMPHOMA 56 0.0878
59 DERMATITIS PSORIASIFORM 136 0.0858
60 TINEA PEDIS 117 0.0858
61 DEVICE DEFECTIVE 529 0.0846
62 SKIN HAEMORRHAGE 828 0.0845
63 GLOSSODYNIA 1405 0.0822
64 PERICARDITIS 916 0.0821
65 ALANINE AMINOTRANSFERASE ABNORMAL 128 0.0800
66 CONCOMITANT DISEASE AGGRAVATED 425 0.0798
67 MUSCLE INJURY 389 0.0796
68 WRONG SCHEDULE 61 0.0788
69 GRIP STRENGTH DECREASED 464 0.0784
70 WOUND 1588 0.0767
71 SKIN LESION 1669 0.0755
72 PRODUCT DISTRIBUTION ISSUE 271 0.0753
73 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3877 0.0751
74 VULVOVAGINAL CANDIDIASIS 74 0.0744
75 LIVER INJURY 1192 0.0744
76 SKIN FISSURES 834 0.0704
77 BLOOD PARATHYROID HORMONE DECREASED 91 0.0702
78 PAPULE 366 0.0692
79 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 797 0.0691
80 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 138 0.0689
81 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 261 0.0687
82 TONSILLITIS 291 0.0686
83 ONYCHOLYSIS 78 0.0648
84 CONTRAINDICATED PRODUCT ADMINISTERED 1496 0.0641
85 THERAPEUTIC RESPONSE SHORTENED 1059 0.0626
86 SPINAL PAIN 594 0.0617
87 SYSTEMIC LUPUS ERYTHEMATOSUS 1514 0.0610
88 PIGMENTATION DISORDER 306 0.0608
89 SPONDYLITIS 166 0.0605
90 FIBROMYALGIA 1116 0.0594
91 THERAPEUTIC PRODUCT EFFECT DECREASED 1900 0.0591
92 AUTOIMMUNE DISORDER 364 0.0582
93 SEBORRHOEIC DERMATITIS 73 0.0580
94 IMPETIGO 68 0.0574
95 ORAL CANDIDIASIS 584 0.0574
96 PHARYNGITIS STREPTOCOCCAL 486 0.0573
97 BURSITIS 488 0.0573
98 ONYCHALGIA 46 0.0569
99 RUBBER SENSITIVITY 65 0.0569
100 PANNICULITIS 110 0.0566
101 PRODUCT SUPPLY ISSUE 262 0.0566
102 UVEITIS 565 0.0566
103 ONYCHOMADESIS 149 0.0564
104 MUSCULOSKELETAL STIFFNESS 4010 0.0550
105 RED BLOOD CELL SEDIMENTATION RATE INCREASED 495 0.0542
106 LIP DRY 302 0.0536
107 THERAPEUTIC PRODUCT EFFECT DELAYED 163 0.0534
108 INFLAMMATION 2107 0.0532
109 ARTHRITIS 3444 0.0530
110 RHEUMATOID NODULE 131 0.0522
111 ADJUSTMENT DISORDER 52 0.0513
112 IRRITABLE BOWEL SYNDROME 815 0.0513
113 RHEUMATIC DISORDER 83 0.0509
114 INFLAMMATORY BOWEL DISEASE 428 0.0507
115 SKIN DEPIGMENTATION 58 0.0507
116 CANDIDA INFECTION 645 0.0504
117 LOWER RESPIRATORY TRACT INFECTION 1669 0.0500
118 FINGER DEFORMITY 185 0.0497
119 EAR INFECTION 1012 0.0495
120 VEIN RUPTURE 64 0.0495
121 TENDERNESS 444 0.0495
122 ARTHROPATHY 2283 0.0494
123 SCRATCH 354 0.0490
124 ERYSIPELAS 205 0.0487
125 LIP ULCERATION 47 0.0483
126 INJECTION RELATED REACTION 54 0.0481
127 SKIN HYPERTROPHY 111 0.0477
128 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 99 0.0475
129 PRODUCT PRESCRIBING ERROR 788 0.0472
130 NAIL DISORDER 299 0.0471
131 OTORRHOEA 68 0.0469
132 DANDRUFF 83 0.0469
133 SCAB 430 0.0469
134 C-REACTIVE PROTEIN INCREASED 1324 0.0459
135 INCORRECT DOSE ADMINISTERED BY DEVICE 682 0.0457
136 WOUND INFECTION 336 0.0448
137 JOINT RANGE OF MOTION DECREASED 428 0.0444
138 SKIN MASS 229 0.0442
139 FEAR OF INJECTION 212 0.0439
140 DERMATITIS EXFOLIATIVE GENERALISED 98 0.0430
141 JOINT DESTRUCTION 56 0.0428
142 SKIN WOUND 49 0.0425
143 GAIT INABILITY 965 0.0425
144 SKIN INJURY 115 0.0422
145 IRITIS 108 0.0422
146 ACTINIC KERATOSIS 96 0.0421
147 ORAL FUNGAL INFECTION 98 0.0420
148 TREATMENT FAILURE 2612 0.0415
149 LATENT TUBERCULOSIS 67 0.0413
150 OESOPHAGEAL CANDIDIASIS 128 0.0409
151 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4558 0.0409
152 APHTHOUS ULCER 228 0.0408
153 SKIN EXFOLIATION 2624 0.0407
154 LARYNGITIS 347 0.0406
155 JOINT STIFFNESS 886 0.0405
156 DISCOMFORT 1815 0.0397
157 VITILIGO 62 0.0393
158 SKIN DISORDER 1050 0.0392
159 JOINT SWELLING 3785 0.0391
160 NEOPLASM SKIN 49 0.0383
161 PYODERMA GANGRENOSUM 97 0.0382
162 HIDRADENITIS 204 0.0381
163 ILLNESS 2014 0.0379
164 HYPERCHOLESTEROLAEMIA 258 0.0379
165 DEVICE MALFUNCTION 1839 0.0376
166 SARS-COV-2 TEST POSITIVE 414 0.0376
167 THERAPY INTERRUPTED 1322 0.0376
168 NASOPHARYNGITIS 5445 0.0374
169 ONYCHOMYCOSIS 117 0.0369
170 EXOSTOSIS 271 0.0368
171 SCIATICA 434 0.0367
172 JOINT NOISE 51 0.0364
173 INJECTION SITE BRUISING 2246 0.0361
174 SKIN WEEPING 46 0.0358
175 LICHEN PLANUS 65 0.0355
176 ARTHRALGIA 11711 0.0354
177 PHARYNGITIS 376 0.0354
178 TUBERCULOSIS 379 0.0353
179 INJECTION SITE URTICARIA 650 0.0352
180 PRODUCT TEMPERATURE EXCURSION ISSUE 75 0.0352
181 STREPTOCOCCAL INFECTION 151 0.0349
182 SINUSITIS 2897 0.0343
183 FURUNCLE 230 0.0341
184 HIP ARTHROPLASTY 388 0.0337
185 TONSILLAR HYPERTROPHY 46 0.0337
186 BLISTER 1503 0.0336
187 NEEDLE ISSUE 649 0.0335
188 TOOTH ABSCESS 297 0.0334
189 SKIN INFECTION 294 0.0334
190 INFECTION SUSCEPTIBILITY INCREASED 57 0.0334
191 BREAST CANCER STAGE III 150 0.0330
192 COSTOCHONDRITIS 46 0.0330
193 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2336 0.0328
194 ABSCESS LIMB 112 0.0327
195 RHINITIS 214 0.0327
196 EAR SWELLING 53 0.0326
197 THERAPEUTIC PRODUCT INEFFECTIVE 109 0.0326
198 LIVE BIRTH 191 0.0325
199 LIMB DEFORMITY 47 0.0325
200 INFLUENZA 2738 0.0324
201 UPPER RESPIRATORY TRACT INFECTION 1207 0.0323
202 LUPUS-LIKE SYNDROME 224 0.0322
203 THERAPY NON-RESPONDER 1006 0.0321
204 DRUG INTOLERANCE 2451 0.0321
205 PRESCRIBED OVERDOSE 503 0.0320
206 IMMUNE SYSTEM DISORDER 341 0.0320
207 JOINT DISLOCATION 270 0.0319
208 INJECTION SITE DISCHARGE 55 0.0319
209 GRANULOMA 90 0.0314
210 SWELLING 2383 0.0314
211 COVID-19 4034 0.0312
212 CORONAVIRUS INFECTION 168 0.0312
213 SECRETION DISCHARGE 288 0.0312
214 MUSCULOSKELETAL DISCOMFORT 443 0.0311
215 INJECTION SITE REACTION 1764 0.0311
216 OSTEOARTHRITIS 1065 0.0309
217 SUSPECTED COVID-19 91 0.0309
218 PLANTAR FASCIITIS 86 0.0308
219 EYE INFECTION 267 0.0308
220 NECK PAIN 1425 0.0307
221 INFLAMMATORY MARKER INCREASED 111 0.0305
222 SKIN DISCOMFORT 58 0.0304
223 MATERNAL EXPOSURE TIMING UNSPECIFIED 81 0.0304
224 INJECTION SITE HYPERSENSITIVITY 60 0.0302
225 LOCALISED INFECTION 606 0.0302
226 INCORRECT DOSE ADMINISTERED 4747 0.0302
227 INJECTION SITE SWELLING 1778 0.0301
228 DENGUE FEVER 49 0.0301
229 IRIDOCYCLITIS 68 0.0300
230 DRUG EFFECT INCOMPLETE 1090 0.0299
231 INJECTION SITE DISCOMFORT 226 0.0299
232 PERSONALITY DISORDER 67 0.0298
233 FOOT DEFORMITY 269 0.0298
234 DRUG EFFECT LESS THAN EXPECTED 161 0.0297
235 TUBERCULIN TEST POSITIVE 72 0.0297
236 ANIMAL BITE 63 0.0296
237 TYPE 2 DIABETES MELLITUS 815 0.0296
238 OROPHARYNGEAL PAIN 2238 0.0296
239 CELLULITIS 1268 0.0295
240 NORMAL NEWBORN 133 0.0293
241 PRODUCT DOSE OMISSION ISSUE 4387 0.0289
242 POLYARTHRITIS 115 0.0288
243 TOOTH INFECTION 313 0.0288
244 KNEE ARTHROPLASTY 445 0.0287
245 FUNGAL INFECTION 786 0.0287
246 HYPOKINESIA 355 0.0284
247 PERIPHERAL SWELLING 3442 0.0283
248 FUNGAL SKIN INFECTION 91 0.0282
249 INJECTION SITE PAIN 6443 0.0281
250 MELANOCYTIC NAEVUS 103 0.0280
251 ACCIDENTAL UNDERDOSE 195 0.0279
252 IMMUNOSUPPRESSION 176 0.0278
253 OBESITY 339 0.0275
254 INFECTION 3124 0.0275
255 MOBILITY DECREASED 1598 0.0275
256 PRURITUS 7542 0.0270
257 BREAKTHROUGH PAIN 58 0.0270
258 ARTHRITIS INFECTIVE 101 0.0268
259 KIDNEY INFECTION 432 0.0268
260 TENDONITIS 360 0.0267
261 SKIN PAPILLOMA 90 0.0267
262 IMPAIRED HEALING 691 0.0264
263 INJECTION SITE MASS 763 0.0262
264 HEPATIC CIRRHOSIS 383 0.0261
265 STRESS 1519 0.0261
266 RESPIRATORY SYMPTOM 46 0.0261
267 PAIN OF SKIN 601 0.0259
268 INJECTION SITE WARMTH 469 0.0259
269 PRODUCT AVAILABILITY ISSUE 327 0.0259
270 SINUS CONGESTION 291 0.0258
271 COLITIS MICROSCOPIC 88 0.0258
272 RESPIRATORY TRACT INFECTION 513 0.0257
273 ACCIDENT 246 0.0257
274 RHINORRHOEA 1309 0.0256
275 MATERNAL EXPOSURE DURING PREGNANCY 1661 0.0256
276 PHARYNGEAL SWELLING 160 0.0256
277 VAGINAL INFECTION 100 0.0256
278 OVERWEIGHT 113 0.0255
279 SUBCUTANEOUS ABSCESS 104 0.0255
280 SKIN ATROPHY 118 0.0254
281 HEPATIC ENZYME INCREASED 1352 0.0252
282 SPINAL FUSION SURGERY 77 0.0250
283 SENSITIVITY TO WEATHER CHANGE 98 0.0249
284 INCORRECT DOSAGE ADMINISTERED 97 0.0248
285 INJECTION SITE INFLAMMATION 97 0.0247
286 RHEUMATOID ARTHRITIS 2262 0.0247
287 JOINT EFFUSION 147 0.0247
288 LOWER LIMB FRACTURE 360 0.0246
289 PAIN 12875 0.0246
290 LIMB DISCOMFORT 630 0.0245
291 MOVEMENT DISORDER 671 0.0245
292 VIRAL UPPER RESPIRATORY TRACT INFECTION 105 0.0244
293 DRUG INEFFECTIVE 26508 0.0244
294 OROPHARYNGEAL DISCOMFORT 150 0.0244
295 CONDITION AGGRAVATED 5581 0.0243
296 ARTHROPOD BITE 149 0.0243
297 SKIN EROSION 59 0.0243
298 ORAL HERPES 368 0.0243
299 INJECTION SITE HAEMORRHAGE 1530 0.0243
300 ACCIDENTAL EXPOSURE TO PRODUCT 1501 0.0242
301 JOINT LOCK 59 0.0241
302 NASAL CONGESTION 1098 0.0240
303 NEAR DEATH EXPERIENCE 51 0.0239
304 INJECTION SITE INJURY 80 0.0238
305 THERAPY CESSATION 948 0.0236
306 LYME DISEASE 64 0.0235
307 HORDEOLUM 67 0.0234
308 INSURANCE ISSUE 154 0.0232
309 INJECTION SITE RASH 536 0.0231
310 EAR DISORDER 89 0.0229
311 BODY TEMPERATURE DECREASED 199 0.0229
312 THERAPEUTIC RESPONSE DELAYED 54 0.0228
313 SKIN SWELLING 131 0.0228
314 RASH PUSTULAR 151 0.0228
315 PRODUCT DISPENSING ERROR 333 0.0227
316 TRIGGER FINGER 73 0.0226
317 BLOOD CHOLESTEROL INCREASED 859 0.0226
318 HEPATIC FIBROSIS 62 0.0226
319 SKIN NECROSIS 102 0.0225
320 LIVER FUNCTION TEST INCREASED 343 0.0225
321 ABDOMINAL DISCOMFORT 3024 0.0223
322 CYST 231 0.0223
323 IMMUNODEFICIENCY 234 0.0223
324 HEPATIC ENZYME ABNORMAL 90 0.0222
325 GASTROINTESTINAL INFECTION 158 0.0222
326 EAR PAIN 354 0.0221
327 DIVERTICULITIS 498 0.0220
328 CREPITATIONS 59 0.0219
329 TONGUE DISORDER 142 0.0218
330 SKIN ABRASION 78 0.0218
331 SPINAL DISORDER 174 0.0218
332 MOUTH ULCERATION 367 0.0217
333 BONE LESION 65 0.0217
334 JOINT INJURY 382 0.0217
335 INJECTION SITE ERYTHEMA 2196 0.0216
336 ORAL INFECTION 70 0.0214
337 TONGUE ULCERATION 62 0.0213
338 PAIN IN EXTREMITY 5366 0.0213
339 EAR CONGESTION 47 0.0212
340 SKIN DISCOLOURATION 816 0.0212
341 BRONCHITIS 1345 0.0211
342 NAIL DISCOLOURATION 69 0.0211
343 VIRAL INFECTION 547 0.0211
344 DYSSTASIA 526 0.0211
345 ECZEMA 532 0.0208
346 VULVOVAGINAL MYCOTIC INFECTION 71 0.0207
347 BASAL CELL CARCINOMA 265 0.0206
348 DIARRHOEA HAEMORRHAGIC 162 0.0206
349 HYPERSENSITIVITY 3158 0.0206
350 NIGHT SWEATS 518 0.0204
351 PRODUCT LEAKAGE 66 0.0203
352 SPINAL STENOSIS 55 0.0201
353 ARTHRITIS BACTERIAL 68 0.0200
354 CYSTITIS 551 0.0200
355 GASTROINTESTINAL PAIN 173 0.0199
356 DEVICE ISSUE 1251 0.0198
357 FACIAL PARALYSIS 130 0.0197
358 STAPHYLOCOCCAL INFECTION 560 0.0196
359 PARANASAL SINUS DISCOMFORT 55 0.0196
360 MENISCUS INJURY 101 0.0196
361 HEPATIC STEATOSIS 298 0.0196
362 BACK INJURY 159 0.0195
363 POST PROCEDURAL INFECTION 123 0.0194
364 POSTOPERATIVE WOUND INFECTION 106 0.0194
365 SCAR 283 0.0194
366 HYPERSENSITIVITY VASCULITIS 49 0.0194
367 SNEEZING 336 0.0192
368 ULCER 256 0.0192
369 BACK PAIN 3732 0.0191
370 SENSORY LOSS 131 0.0191
371 RASH MACULAR 527 0.0191
372 MASS 228 0.0191
373 ROSACEA 70 0.0191
374 HYPERKERATOSIS 87 0.0190
375 PULMONARY FIBROSIS 278 0.0190
376 SINUS DISORDER 310 0.0189
377 COLITIS 539 0.0189
378 STOMATITIS 919 0.0189
379 INFUSION RELATED REACTION 937 0.0189
380 CHONDROPATHY 46 0.0187
381 RASH 6375 0.0185
382 NEPHROLITHIASIS 674 0.0185
383 PROSTATITIS 48 0.0185
384 RED CELL DISTRIBUTION WIDTH INCREASED 61 0.0184
385 MALAISE 6894 0.0184
386 LIMB INJURY 396 0.0184
387 BACTERIAL INFECTION 265 0.0182
388 ONYCHOCLASIS 101 0.0181
389 VARICOSE VEIN 79 0.0180
390 CONJUNCTIVITIS 246 0.0180
391 LIGAMENT SPRAIN 142 0.0179
392 CHAPPED LIPS 65 0.0179
393 GASTRIC INFECTION 55 0.0178
394 GASTROENTERITIS VIRAL 253 0.0178
395 PURULENT DISCHARGE 66 0.0178
396 ANOSMIA 218 0.0178
397 PRODUCT DOSE OMISSION 1180 0.0178
398 MUSCULOSKELETAL PAIN 855 0.0178
399 MALIGNANT MELANOMA 200 0.0177
400 DRUG TOLERANCE 74 0.0176
401 TENDON PAIN 113 0.0175
402 OTITIS MEDIA 49 0.0175
403 ILL-DEFINED DISORDER 832 0.0175
404 ORAL PAIN 332 0.0174
405 FRUSTRATION TOLERANCE DECREASED 108 0.0174
406 HYPOACUSIS 589 0.0174
407 SKIN ULCER 377 0.0174
408 GENERAL PHYSICAL HEALTH DETERIORATION 1498 0.0173
409 NASAL DRYNESS 88 0.0172
410 EYE INFLAMMATION 120 0.0171
411 RESPIRATORY TRACT CONGESTION 217 0.0171
412 SKIN REACTION 194 0.0170
413 HERPES VIRUS INFECTION 81 0.0170
414 MONOCYTE COUNT INCREASED 49 0.0170
415 INJECTION SITE VESICLES 75 0.0170
416 DERMATITIS 262 0.0169
417 INTESTINAL HAEMORRHAGE 81 0.0169
418 SPUTUM DISCOLOURED 128 0.0169
419 PRODUCT STORAGE ERROR 869 0.0168
420 HERPES ZOSTER 810 0.0168
421 WALKING AID USER 86 0.0168
422 DEVICE LEAKAGE 405 0.0167
423 UPPER-AIRWAY COUGH SYNDROME 107 0.0167
424 SYNOVIAL CYST 67 0.0167
425 ALOPECIA 2769 0.0166
426 INJECTION SITE PRURITUS 896 0.0165
427 NASAL DISCOMFORT 112 0.0165
428 WOUND SECRETION 57 0.0165
429 SARCOIDOSIS 64 0.0164
430 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 495 0.0164
431 GASTROINTESTINAL DISORDER 1018 0.0164
432 THYROID MASS 47 0.0164
433 INTERVERTEBRAL DISC DEGENERATION 136 0.0164
434 CONTUSION 1292 0.0163
435 FOOD INTOLERANCE 48 0.0163
436 ROAD TRAFFIC ACCIDENT 562 0.0163
437 PYELONEPHRITIS 114 0.0163
438 FOOD POISONING 65 0.0162
439 PULMONARY CONGESTION 173 0.0162
440 BLOOD PRESSURE SYSTOLIC INCREASED 261 0.0161
441 COLITIS ULCERATIVE 504 0.0161
442 SEASONAL ALLERGY 166 0.0160
443 BLEPHARITIS 46 0.0160
444 GUILLAIN-BARRE SYNDROME 61 0.0160
445 MUSCULOSKELETAL CHEST PAIN 205 0.0160
446 APHONIA 176 0.0159
447 COUGH 3548 0.0159
448 ORAL DISORDER 97 0.0158
449 TONGUE DISCOLOURATION 63 0.0157
450 GLOSSITIS 47 0.0156
451 URTICARIA 2055 0.0155
452 DRUG EFFECT DELAYED 70 0.0154
453 ERYTHEMA 2627 0.0154
454 BLEPHAROSPASM 62 0.0154
455 GINGIVITIS 71 0.0153
456 SENSITIVE SKIN 73 0.0152
457 URINARY TRACT INFECTION 2075 0.0151
458 APPENDICITIS 111 0.0151
459 WHEEZING 677 0.0151
460 GAIT DISTURBANCE 2444 0.0151
461 INJECTION SITE INDURATION 170 0.0151
462 MATERNAL EXPOSURE BEFORE PREGNANCY 74 0.0150
463 DRY SKIN 1476 0.0149
464 THERAPEUTIC RESPONSE DECREASED 713 0.0149
465 LIVER DISORDER 533 0.0149
466 INJECTION SITE DISCOLOURATION 148 0.0148
467 TONGUE DISCOMFORT 48 0.0148
468 SUNBURN 96 0.0148
469 ABSCESS 193 0.0147
470 MOTOR DYSFUNCTION 122 0.0146
471 PROSTATOMEGALY 48 0.0146
472 GLUCOSE TOLERANCE IMPAIRED 69 0.0146
473 EAR DISCOMFORT 120 0.0145
474 PRODUCT USE ISSUE 2125 0.0145
475 PULMONARY MASS 172 0.0145
476 SWELLING OF EYELID 54 0.0144
477 ANAL ABSCESS 60 0.0144
478 BOWEL MOVEMENT IRREGULARITY 84 0.0143
479 PRODUCTIVE COUGH 518 0.0143
480 BURNING SENSATION 847 0.0142
481 PRODUCT ADMINISTRATION ERROR 194 0.0142
482 HEAD DISCOMFORT 195 0.0141
483 NODULE 151 0.0140
484 LYMPHADENOPATHY 410 0.0140
485 OEDEMA 612 0.0140
486 FEELING OF DESPAIR 52 0.0139
487 RASH ERYTHEMATOUS 475 0.0138
488 INFLUENZA LIKE ILLNESS 993 0.0138
489 MUSCLE STRAIN 100 0.0137
490 DRUG-INDUCED LIVER INJURY 287 0.0137
491 LUNG DISORDER 532 0.0136
492 PRESCRIBED UNDERDOSE 217 0.0136
493 COVID-19 PNEUMONIA 125 0.0136
494 THERMAL BURN 83 0.0136
495 NERVE COMPRESSION 102 0.0134
496 DRUG ERUPTION 186 0.0133
497 HAND FRACTURE 78 0.0132
498 DIABETES MELLITUS 876 0.0132
499 LIGAMENT RUPTURE 48 0.0129
500 GOUT 191 0.0129
501 HEMIPLEGIA 93 0.0129
502 CONCUSSION 80 0.0128
503 INJURY 801 0.0127
504 GROIN PAIN 95 0.0127
505 INTERVERTEBRAL DISC PROTRUSION 237 0.0125
506 DERMATITIS CONTACT 113 0.0125
507 RESPIRATORY DISORDER 308 0.0125
508 GASTROENTERITIS 150 0.0124
509 THERAPY PARTIAL RESPONDER 93 0.0124
510 EXPOSURE DURING PREGNANCY 609 0.0124
511 SQUAMOUS CELL CARCINOMA OF SKIN 58 0.0124
512 FOOT FRACTURE 200 0.0124
513 PYREXIA 3556 0.0124
514 ORAL MUCOSAL BLISTERING 66 0.0123
515 AGEUSIA 257 0.0123
516 URINE ODOUR ABNORMAL 62 0.0123
517 PRODUCT USE IN UNAPPROVED INDICATION 2061 0.0123
518 SLEEP DISORDER 670 0.0123
519 ENTERITIS 59 0.0122
520 OSTEOMYELITIS 193 0.0122
521 BLOOD TEST ABNORMAL 135 0.0122
522 BACK DISORDER 165 0.0121
523 RASH PRURITIC 518 0.0121
524 ARTERIAL OCCLUSIVE DISEASE 82 0.0120
525 MIGRAINE 904 0.0119
526 TOOTHACHE 178 0.0119
527 GASTROINTESTINAL INFLAMMATION 72 0.0119
528 INFARCTION 75 0.0119
529 EYE DISCHARGE 91 0.0119
530 FATIGUE 7425 0.0118
531 EATING DISORDER 211 0.0117
532 PRURITUS GENERALISED 252 0.0116
533 CARPAL TUNNEL SYNDROME 136 0.0116
534 PNEUMONIA 2984 0.0115
535 DIARRHOEA 5917 0.0115
536 INCORRECT ROUTE OF DRUG ADMINISTRATION 411 0.0115
537 DEVICE DELIVERY SYSTEM ISSUE 117 0.0115
538 ANKLE FRACTURE 150 0.0115
539 SQUAMOUS CELL CARCINOMA 89 0.0114
540 SKIN TIGHTNESS 46 0.0114
541 PRODUCT LABEL CONFUSION 47 0.0114
542 VASCULITIS 109 0.0114
543 HYPOAESTHESIA 1427 0.0114
544 SKIN LACERATION 91 0.0113
545 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 379 0.0112
546 TENDON DISORDER 62 0.0112
547 UNDERDOSE 666 0.0112
548 BREAST MASS 63 0.0111
549 COELIAC DISEASE 86 0.0111
550 ADVERSE DRUG REACTION 748 0.0111
551 MOUTH SWELLING 51 0.0110
552 DYSLIPIDAEMIA 46 0.0110
553 SPINAL OSTEOARTHRITIS 83 0.0110
554 FEEDING DISORDER 152 0.0109
555 ODYNOPHAGIA 51 0.0109
556 DEAFNESS 231 0.0109
557 VITAMIN D DECREASED 79 0.0108
558 DRUG HYPERSENSITIVITY 1800 0.0108
559 AFFECTIVE DISORDER 68 0.0108
560 ORAL DISCOMFORT 126 0.0108
561 ABDOMINAL PAIN UPPER 1802 0.0108
562 SENSATION OF FOREIGN BODY 71 0.0107
563 INGUINAL HERNIA 55 0.0107
564 TASTE DISORDER 132 0.0106
565 SINUS HEADACHE 56 0.0106
566 VITAMIN D DEFICIENCY 85 0.0106
567 HYPERTENSION 1849 0.0106
568 GASTRIC DISORDER 371 0.0106
569 DEAFNESS UNILATERAL 48 0.0106
570 DRY THROAT 89 0.0106
571 INJECTION SITE EXTRAVASATION 124 0.0105
572 RIB FRACTURE 179 0.0105
573 INTENTIONAL PRODUCT USE ISSUE 707 0.0104
574 ENERGY INCREASED 54 0.0104
575 DYSURIA 326 0.0104
576 RENAL PAIN 91 0.0104
577 LYMPHOMA 137 0.0104
578 UPPER LIMB FRACTURE 179 0.0103
579 HERPES SIMPLEX 53 0.0102
580 HERNIA 157 0.0102
581 BONE PAIN 500 0.0102
582 BLOOD URIC ACID INCREASED 47 0.0101
583 HYPERCALCAEMIA 103 0.0101
584 CEREBRAL DISORDER 59 0.0101
585 PLEURISY 53 0.0101
586 INJECTION SITE IRRITATION 105 0.0100
587 NEOPLASM MALIGNANT 535 0.0100
588 DRY MOUTH 657 0.0100
589 FEELING ABNORMAL 2094 0.0100
590 ROTATOR CUFF SYNDROME 110 0.0100
591 NERVOUSNESS 466 0.0100
592 DERMATITIS ALLERGIC 95 0.0099
593 AFFECT LABILITY 84 0.0099
594 HYPERAESTHESIA 72 0.0098
595 HAEMATOCHEZIA 430 0.0098
596 PHOTOSENSITIVITY REACTION 136 0.0098
597 OSTEOPOROSIS 343 0.0098
598 HEPATITIS B 51 0.0097
599 SKIN IRRITATION 386 0.0097
600 SKIN HYPERPIGMENTATION 71 0.0097
601 INTENTIONAL DOSE OMISSION 123 0.0097
602 DISABILITY 156 0.0097
603 MEMORY IMPAIRMENT 1116 0.0097
604 HEPATOMEGALY 84 0.0096
605 RENAL CYST 66 0.0096
606 THROAT IRRITATION 345 0.0096
607 SPINAL OPERATION 78 0.0096
608 DYSPHONIA 457 0.0096
609 NEURALGIA 187 0.0096
610 GLOMERULAR FILTRATION RATE DECREASED 84 0.0095
611 GENERAL PHYSICAL CONDITION ABNORMAL 54 0.0095
612 HEADACHE 4975 0.0095
613 DEFORMITY 80 0.0094
614 LIP SWELLING 262 0.0094
615 SKIN CANCER 166 0.0094
616 FAECES SOFT 46 0.0094
617 BODY TEMPERATURE INCREASED 166 0.0094
618 DRUG EFFECT DECREASED 507 0.0094
619 GINGIVAL PAIN 62 0.0094
620 DELIRIUM 259 0.0094
621 MUSCLE SPASTICITY 103 0.0093
622 DEPRESSED MOOD 396 0.0093
623 THERAPY CHANGE 59 0.0091
624 WRIST FRACTURE 91 0.0091
625 SCOLIOSIS 48 0.0090
626 SWELLING FACE 487 0.0090
627 EYE SWELLING 271 0.0090
628 PRODUCT PACKAGING ISSUE 64 0.0089
629 NEOPLASM 82 0.0088
630 ASTHMA 721 0.0088
631 CHILLS 867 0.0088
632 PRODUCT PRESCRIBING ISSUE 76 0.0088
633 FEELING HOT 457 0.0088
634 ANGINA PECTORIS 221 0.0087
635 THYROID DISORDER 109 0.0087
636 PEMPHIGOID 48 0.0086
637 BREAST CANCER STAGE II 65 0.0086
638 POLYP 47 0.0086
639 PELVIC PAIN 130 0.0086
640 MUSCULAR WEAKNESS 806 0.0085
641 DYSPEPSIA 677 0.0085
642 HEPATITIS 177 0.0084
643 SLUGGISHNESS 72 0.0084
644 BONE DISORDER 138 0.0084
645 OCULAR DISCOMFORT 62 0.0084
646 TENDON RUPTURE 90 0.0084
647 BLOOD ALBUMIN DECREASED 56 0.0083
648 ULCER HAEMORRHAGE 47 0.0083
649 BRAIN INJURY 69 0.0083
650 SWOLLEN TONGUE 223 0.0083
651 BLADDER DISORDER 71 0.0083
652 WEIGHT DECREASED 1906 0.0082
653 GASTRITIS 182 0.0082
654 HAEMORRHOIDS 134 0.0081
655 AMNESIA 458 0.0081
656 BLOOD IRON DECREASED 72 0.0080
657 ABDOMINAL PAIN 1540 0.0080
658 MUSCULOSKELETAL DISORDER 133 0.0080
659 ADVERSE REACTION 87 0.0080
660 ACNE 530 0.0079
661 OCULAR HYPERAEMIA 279 0.0079
662 BLOOD URINE PRESENT 129 0.0079
663 HEPATOCELLULAR CARCINOMA 50 0.0079
664 INJURY ASSOCIATED WITH DEVICE 119 0.0079
665 PAROSMIA 49 0.0079
666 WHITE BLOOD CELL COUNT INCREASED 260 0.0079
667 WEIGHT INCREASED 1426 0.0078
668 ESCHERICHIA INFECTION 50 0.0078
669 CHEST PAIN 1239 0.0078
670 THROAT TIGHTNESS 176 0.0078
671 POOR QUALITY SLEEP 133 0.0078
672 CATARACT 362 0.0078
673 RASH GENERALISED 201 0.0077
674 DRY EYE 257 0.0077
675 CHEST DISCOMFORT 638 0.0077
676 SLEEP APNOEA SYNDROME 128 0.0077
677 EYE DISORDER 203 0.0076
678 SYRINGE ISSUE 91 0.0076
679 COLON CANCER 95 0.0076
680 QUALITY OF LIFE DECREASED 85 0.0076
681 KNEE OPERATION 53 0.0076
682 DEVICE FAILURE 91 0.0075
683 BLOOD PRESSURE DIASTOLIC DECREASED 47 0.0075
684 BLOOD TRIGLYCERIDES INCREASED 114 0.0075
685 LACRIMATION INCREASED 171 0.0075
686 LOWER GASTROINTESTINAL HAEMORRHAGE 50 0.0075
687 TOOTH FRACTURE 70 0.0075
688 DRUG PRESCRIBING ERROR 143 0.0074
689 FLANK PAIN 58 0.0074
690 INCORRECT PRODUCT STORAGE 97 0.0074
691 ARTERIOSCLEROSIS 60 0.0074
692 VISUAL IMPAIRMENT 707 0.0073
693 SPLENOMEGALY 72 0.0073
694 DISEASE RECURRENCE 254 0.0073
695 EOSINOPHIL COUNT INCREASED 48 0.0072
696 PHOTOPHOBIA 106 0.0071
697 EYE PRURITUS 166 0.0071
698 BREAST PAIN 66 0.0071
699 MYALGIA 998 0.0070
700 FALL 1931 0.0070
701 NERVE INJURY 67 0.0070
702 GASTRIC ULCER 114 0.0070
703 PLATELET COUNT INCREASED 75 0.0069
704 EJECTION FRACTION DECREASED 90 0.0069
705 ALANINE AMINOTRANSFERASE INCREASED 362 0.0069
706 FREQUENT BOWEL MOVEMENTS 138 0.0069
707 CLOSTRIDIUM DIFFICILE INFECTION 117 0.0069
708 INSOMNIA 1561 0.0069
709 SKIN BURNING SENSATION 415 0.0069
710 PARAESTHESIA ORAL 80 0.0069
711 RENAL DISORDER 267 0.0068
712 CONFUSIONAL STATE 933 0.0068
713 BLOOD DISORDER 46 0.0068
714 BLOOD PRESSURE ABNORMAL 105 0.0068
715 LUNG INFECTION 106 0.0068
716 COORDINATION ABNORMAL 85 0.0068
717 VERTIGO 350 0.0068
718 DYSPHAGIA 515 0.0068
719 PREGNANCY 124 0.0068
720 WEIGHT FLUCTUATION 55 0.0068
721 MENTAL DISORDER 245 0.0067
722 PARAESTHESIA 909 0.0067
723 BLOOD PRESSURE INCREASED 854 0.0067
724 NAUSEA 4350 0.0067
725 DECREASED APPETITE 1236 0.0067
726 LETHARGY 327 0.0067
727 FACIAL PAIN 49 0.0067
728 HEMIPARESIS 99 0.0067
729 MUSCLE SPASMS 1016 0.0066
730 FEELING COLD 155 0.0066
731 SPEECH DISORDER 293 0.0066
732 DECREASED ACTIVITY 56 0.0066
733 SURGERY 279 0.0066
734 ABDOMINAL DISTENSION 551 0.0065
735 MUSCLE TIGHTNESS 90 0.0065
736 TEMPERATURE INTOLERANCE 53 0.0065
737 EMPHYSEMA 57 0.0065
738 MUSCLE ATROPHY 63 0.0065
739 TRANSAMINASES INCREASED 121 0.0065
740 BRAIN NEOPLASM 48 0.0065
741 POST PROCEDURAL COMPLICATION 105 0.0064
742 THYROID CANCER 70 0.0064
743 ASTHENIA 1985 0.0064
744 DRUG DOSE OMISSION BY DEVICE 177 0.0064
745 DEPRESSION 1263 0.0064
746 SPINAL FRACTURE 101 0.0063
747 ANGIOEDEMA 230 0.0063
748 DYSPNOEA 2949 0.0063
749 NO ADVERSE EVENT 770 0.0063
750 ANAPHYLACTIC REACTION 264 0.0062
751 GASTROOESOPHAGEAL REFLUX DISEASE 405 0.0062
752 POLLAKIURIA 215 0.0062
753 PHARYNGEAL OEDEMA 94 0.0062
754 FEAR 152 0.0062
755 SEPSIS 573 0.0062
756 ANXIETY 1500 0.0062
757 HYPERHIDROSIS 677 0.0061
758 SEXUAL DYSFUNCTION 58 0.0061
759 APHASIA 157 0.0061
760 HIP FRACTURE 160 0.0061
761 CRYING 195 0.0060
762 CARDIAC DISORDER 485 0.0060
763 CHOLELITHIASIS 166 0.0060
764 PARALYSIS 73 0.0060
765 DIZZINESS 2483 0.0060
766 HYPOAESTHESIA ORAL 76 0.0060
767 DEMENTIA 128 0.0060
768 MICTURITION URGENCY 55 0.0059
769 CEREBROVASCULAR ACCIDENT 876 0.0059
770 HYPERSOMNIA 139 0.0059
771 VOMITING 2249 0.0059
772 LEUKAEMIA 46 0.0058
773 GALLBLADDER DISORDER 91 0.0058
774 HEAD INJURY 150 0.0058
775 EYE PAIN 244 0.0058
776 ABDOMINAL PAIN LOWER 124 0.0058
777 ADVERSE EVENT 433 0.0057
778 OESOPHAGITIS 51 0.0056
779 CHOKING 88 0.0056
780 OFF LABEL USE 3406 0.0056
781 BLINDNESS UNILATERAL 65 0.0056
782 BREAST CANCER 488 0.0056
783 HOT FLUSH 321 0.0055
784 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 852 0.0055
785 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 240 0.0055
786 OEDEMA PERIPHERAL 590 0.0055
787 HYPOTHYROIDISM 137 0.0054
788 INTESTINAL PERFORATION 50 0.0054
789 HYPERLIPIDAEMIA 57 0.0054
790 NEUTROPHIL COUNT INCREASED 47 0.0054
791 RECTAL HAEMORRHAGE 198 0.0054
792 PRODUCT DOSE OMISSION IN ERROR 59 0.0054
793 HEPATITIS C 61 0.0054
794 HIATUS HERNIA 60 0.0053
795 MIDDLE INSOMNIA 79 0.0053
796 BLOOD CREATININE INCREASED 297 0.0053
797 DENTAL CARIES 50 0.0053
798 HYPERTHYROIDISM 61 0.0053
799 CLOSTRIDIUM DIFFICILE COLITIS 45 0.0052
800 ASPARTATE AMINOTRANSFERASE INCREASED 234 0.0052
801 PANIC ATTACK 157 0.0051
802 HAEMORRHAGE 432 0.0051
803 CHROMATURIA 98 0.0051
804 HEART RATE INCREASED 417 0.0051
805 THROMBOSIS 348 0.0051
806 THERAPEUTIC RESPONSE UNEXPECTED 196 0.0051
807 NERVOUS SYSTEM DISORDER 140 0.0050
808 OSTEOPENIA 67 0.0050
809 LUNG NEOPLASM MALIGNANT 185 0.0050
810 DEVICE USE ISSUE 54 0.0049
811 EYELID OEDEMA 52 0.0049
812 PAIN IN JAW 119 0.0049
813 ABORTION SPONTANEOUS 167 0.0048
814 FRACTURE 77 0.0048
815 FLUID RETENTION 208 0.0048
816 DYSARTHRIA 154 0.0048
817 MYOCARDIAL INFARCTION 766 0.0048
818 GAMMA-GLUTAMYLTRANSFERASE INCREASED 93 0.0048
819 MUSCLE RIGIDITY 47 0.0047
820 FLATULENCE 218 0.0047
821 GLYCOSYLATED HAEMOGLOBIN INCREASED 95 0.0047
822 BIPOLAR DISORDER 45 0.0047
823 EXTRA DOSE ADMINISTERED 113 0.0046
824 TOOTH DISORDER 89 0.0046
825 GINGIVAL BLEEDING 49 0.0046
826 PANCREATITIS 205 0.0046
827 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 55 0.0046
828 DERMATITIS ATOPIC 72 0.0046
829 EPILEPSY 109 0.0045
830 MOOD ALTERED 102 0.0045
831 RASH PAPULAR 87 0.0045
832 BLINDNESS 145 0.0044
833 GLAUCOMA 71 0.0044
834 PALPITATIONS 428 0.0044
835 RENAL IMPAIRMENT 294 0.0044
836 BLOOD PRESSURE DECREASED 240 0.0043
837 HAEMOPTYSIS 101 0.0043
838 PROSTATIC SPECIFIC ANTIGEN INCREASED 49 0.0042
839 FAECES DISCOLOURED 77 0.0042
840 COLD SWEAT 62 0.0042
841 CORONARY ARTERY OCCLUSION 51 0.0041
842 INCREASED APPETITE 57 0.0041
843 SYNCOPE 346 0.0041
844 HEPATOTOXICITY 72 0.0041
845 PERIPHERAL COLDNESS 47 0.0041
846 SUICIDAL IDEATION 312 0.0040
847 ANAPHYLACTIC SHOCK 81 0.0040
848 FACE OEDEMA 58 0.0040
849 MULTIPLE SCLEROSIS 164 0.0040
850 LEUKOPENIA 161 0.0040
851 HAEMATURIA 118 0.0040
852 ATRIAL FIBRILLATION 322 0.0040
853 PROCEDURAL PAIN 86 0.0040
854 TRANSIENT ISCHAEMIC ATTACK 116 0.0039
855 DRUG DISPENSING ERROR 60 0.0039
856 NEUROPATHY PERIPHERAL 288 0.0039
857 INTERSTITIAL LUNG DISEASE 149 0.0039
858 PNEUMOTHORAX 50 0.0039
859 DEVICE RELATED INFECTION 52 0.0039
860 SENSORY DISTURBANCE 55 0.0038
861 EMOTIONAL DISORDER 101 0.0038
862 THIRST 55 0.0037
863 LIVER FUNCTION TEST ABNORMAL 99 0.0037
864 ACUTE MYOCARDIAL INFARCTION 97 0.0037
865 RESTLESS LEGS SYNDROME 58 0.0037
866 MOOD SWINGS 104 0.0037
867 DRUG RESISTANCE 75 0.0037
868 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 153 0.0037
869 VISION BLURRED 411 0.0037
870 PALLOR 85 0.0036
871 DIABETES MELLITUS INADEQUATE CONTROL 54 0.0036
872 TINNITUS 138 0.0036
873 HEPATIC FAILURE 92 0.0036
874 HAEMATOCRIT DECREASED 63 0.0036
875 BLOOD POTASSIUM INCREASED 49 0.0036
876 PRESYNCOPE 70 0.0035
877 EYE IRRITATION 142 0.0035
878 PNEUMONITIS 72 0.0035
879 BLOOD PRESSURE FLUCTUATION 72 0.0035
880 MULTIPLE ORGAN DYSFUNCTION SYNDROME 68 0.0034
881 MEDICATION ERROR 159 0.0034
882 MULTIPLE FRACTURES 51 0.0034
883 LOSS OF CONSCIOUSNESS 368 0.0034
884 FEMUR FRACTURE 93 0.0034
885 HEART RATE DECREASED 102 0.0034
886 SEIZURE 294 0.0034
887 SOMNOLENCE 562 0.0034
888 DRUG ADMINISTRATION ERROR 103 0.0034
889 RETCHING 58 0.0033
890 INTESTINAL OBSTRUCTION 97 0.0033
891 DYSPNOEA EXERTIONAL 98 0.0033
892 CARDIAC FAILURE 219 0.0033
893 CORONARY ARTERY DISEASE 92 0.0033
894 ANGER 97 0.0033
895 DEHYDRATION 367 0.0033
896 ARRHYTHMIA 132 0.0032
897 CONSTIPATION 541 0.0032
898 URINARY INCONTINENCE 79 0.0032
899 RED BLOOD CELL COUNT DECREASED 75 0.0032
900 CIRCULATORY COLLAPSE 47 0.0032
901 TOOTH LOSS 57 0.0031
902 CARDIAC FAILURE CONGESTIVE 233 0.0031
903 BLOOD GLUCOSE INCREASED 507 0.0031
904 LEUKOCYTOSIS 46 0.0031
905 PROSTATE CANCER 237 0.0031
906 SEPTIC SHOCK 105 0.0031
907 TACHYCARDIA 226 0.0031
908 DEATH 2136 0.0030
909 BLOOD GLUCOSE ABNORMAL 47 0.0030
910 ASCITES 74 0.0030
911 DYSGEUSIA 194 0.0030
912 HAEMATOMA 67 0.0029
913 DEVICE DIFFICULT TO USE 111 0.0029
914 EPISTAXIS 184 0.0029
915 IRRITABILITY 153 0.0029
916 BLOOD ALKALINE PHOSPHATASE INCREASED 64 0.0029
917 DEVICE BREAKAGE 68 0.0029
918 PULMONARY EMBOLISM 240 0.0029
919 UNEVALUABLE EVENT 191 0.0029
920 BLOOD SODIUM DECREASED 45 0.0029
921 DEEP VEIN THROMBOSIS 167 0.0029
922 TREATMENT NONCOMPLIANCE 117 0.0028
923 MENTAL IMPAIRMENT 57 0.0028
924 LABORATORY TEST ABNORMAL 67 0.0028
925 BALANCE DISORDER 204 0.0028
926 COGNITIVE DISORDER 106 0.0028
927 DIPLOPIA 58 0.0027
928 WHITE BLOOD CELL COUNT DECREASED 243 0.0027
929 HEPATIC CANCER 62 0.0027
930 BLOOD POTASSIUM DECREASED 68 0.0027
931 HOSPITALISATION 305 0.0027
932 HEART RATE IRREGULAR 54 0.0027
933 ERECTILE DYSFUNCTION 56 0.0027
934 PULMONARY OEDEMA 101 0.0027
935 HAEMOGLOBIN DECREASED 229 0.0026
936 ANAEMIA 421 0.0026
937 CARDIOVASCULAR DISORDER 61 0.0026
938 PANCREATITIS ACUTE 47 0.0026
939 TREMOR 368 0.0026
940 MUSCLE TWITCHING 51 0.0026
941 PLEURAL EFFUSION 132 0.0026
942 PERICARDIAL EFFUSION 46 0.0025
943 BLOOD GLUCOSE DECREASED 102 0.0024
944 OSTEONECROSIS 73 0.0024
945 URINARY RETENTION 66 0.0024
946 RENAL FAILURE 284 0.0024
947 OXYGEN SATURATION DECREASED 102 0.0024
948 BLOOD BILIRUBIN INCREASED 55 0.0024
949 CEREBRAL INFARCTION 49 0.0023
950 EMOTIONAL DISTRESS 263 0.0023
951 RESTLESSNESS 72 0.0023
952 PNEUMONIA ASPIRATION 46 0.0023
953 MUCOSAL INFLAMMATION 48 0.0023
954 FLUSHING 201 0.0022
955 HAEMATEMESIS 48 0.0022
956 ACCIDENTAL OVERDOSE 61 0.0021
957 DEVICE USE ERROR 54 0.0021
958 CEREBRAL HAEMORRHAGE 63 0.0021
959 DISORIENTATION 71 0.0020
960 PANCREATIC CARCINOMA 54 0.0020
961 NIGHTMARE 60 0.0020
962 EXPIRED PRODUCT ADMINISTERED 54 0.0020
963 HYPOGLYCAEMIA 81 0.0020
964 JAUNDICE 46 0.0019
965 HYPOTENSION 322 0.0019
966 DISTURBANCE IN ATTENTION 89 0.0019
967 HEPATIC FUNCTION ABNORMAL 55 0.0019
968 PLATELET COUNT DECREASED 163 0.0019
969 BLADDER CANCER 103 0.0018
970 THROMBOCYTOPENIA 162 0.0018
971 DRUG DOSE OMISSION 296 0.0018
972 RESPIRATORY FAILURE 107 0.0017
973 HYPERGLYCAEMIA 52 0.0017
974 GASTROINTESTINAL HAEMORRHAGE 125 0.0017
975 COMA 66 0.0016
976 VAGINAL HAEMORRHAGE 61 0.0016
977 HYPOKALAEMIA 59 0.0016
978 OVERDOSE 284 0.0015
979 DISEASE PROGRESSION 140 0.0015
980 DYSKINESIA 51 0.0015
981 FOETAL EXPOSURE DURING PREGNANCY 97 0.0015
982 RENAL CANCER 68 0.0015
983 WITHDRAWAL SYNDROME 48 0.0015
984 AGITATION 90 0.0014
985 CARDIAC ARREST 99 0.0014
986 ACUTE KIDNEY INJURY 163 0.0014
987 CHRONIC KIDNEY DISEASE 93 0.0013
988 DRUG INTERACTION 175 0.0013
989 PRODUCT QUALITY ISSUE 160 0.0013
990 NEUTROPENIA 127 0.0012
991 SUICIDE ATTEMPT 56 0.0011
992 PANCYTOPENIA 49 0.0011
993 INTENTIONAL PRODUCT MISUSE 62 0.0009
994 TOXICITY TO VARIOUS AGENTS 52 0.0004